Advanced Medical Isotope (OTC: ADMD) is a late-stage radiation oncology-focused medical device company developing yttrium-90-based brachytherapy devices for the treatment of non-resectable tumors. The company’s IsoPet Solutions division is focused on establishing the infrastructure necessary to provide its product to veterinary clinics, as well as providing product awareness and education to veterinary oncologists. Advanced Medical Isotope intends to outsource material aspects of manufacturing, distribution, sales and marketing for its products in the United States and to enter into licensing arrangements outside of the United States, though the company will evaluate its alternatives before finalizing its plans. For more information, visit the company’s website at www.isotopeworld.com